About Luoxin Pharmaceutical Group
Luoxin Pharmaceutical Group was founded in 2006 in Linyi, China, within the pharmaceutical sector. Operations encompass research and development of drug formulations across therapeutic fields such as gastroenterology, pediatrics, respiratory, and oncology. Manufacturing facilities are utilized for production, while distribution networks facilitate market access. Standards for drug safety and vigilance are consistently applied throughout activities.
- Headquarter Linyi, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$360.3 M (USD)12.12as on Dec 31, 2024
-
Net Profit
-$132.27 M (USD)-46.04as on Dec 31, 2024
-
EBITDA
-$79.06 M (USD)-115.64as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Ally Bridge Group
(Mar 16, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Luoxin Pharmaceutical Group
Detailed funding history for Luoxin Pharmaceutical Group
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Luoxin Pharmaceutical Group
Luoxin Pharmaceutical Group has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ally Bridge Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked |
Investor details for Luoxin Pharmaceutical Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Luoxin Pharmaceutical Group
Investment portfolio details for Luoxin Pharmaceutical Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Luoxin Pharmaceutical Group
Detailed financials for Luoxin Pharmaceutical Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Luoxin Pharmaceutical Group Comparisons
Peer comparison for Luoxin Pharmaceutical Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Luoxin Pharmaceutical Group
Detailed competitors of Luoxin Pharmaceutical Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Luoxin Pharmaceutical Group
Complete news archive for Luoxin Pharmaceutical Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Luoxin Pharmaceutical Group
Luoxin Pharmaceutical Group was founded in 2006.
Luoxin Pharmaceutical Group is headquartered in Linyi, China. It is registered at Linyi, Shandong, China.
Annual revenue of Luoxin Pharmaceutical Group is $360.3M as on Dec 31, 2024.
Luoxin Pharmaceutical Group was founded in 2006 in Linyi, China, within the pharmaceutical sector. Operations encompass research and development of drug formulations across therapeutic fields such as gastroenterology, pediatrics, respiratory, and oncology. Manufacturing facilities are utilized for production, while distribution networks facilitate market access. Standards for drug safety and vigilance are consistently applied throughout activities.
Luoxin Pharmaceutical Group has 1 investor. Key investors include Ally Bridge Group.